Cargando…

Single Gene Prognostic Biomarkers in Ovarian Cancer: A Meta-Analysis

PURPOSE: To discover novel prognostic biomarkers in ovarian serous carcinomas. METHODS: A meta-analysis of all single genes probes in the TCGA and HAS ovarian cohorts was performed to identify possible biomarkers using Cox regression as a continuous variable for overall survival. Genes were ranked b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Willis, Scooter, Villalobos, Victor M., Gevaert, Olivier, Abramovitz, Mark, Williams, Casey, Sikic, Branimir I., Leyland-Jones, Brian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757072/ https://www.ncbi.nlm.nih.gov/pubmed/26886260 http://dx.doi.org/10.1371/journal.pone.0149183

Ejemplares similares

Exploratory Analysis of Single-Gene Predictive Biomarkers in HERA DASL Cohort Reveals That C8A mRNA Expression Is Prognostic of Outcome and Predictive of Benefit of Trastuzumab
por: Willis, Scooter, et al.
Publicado: (2018)

A systems approach to clinical oncology: Focus on breast cancer
por: Abramovitz, Mark, et al.
Publicado: (2006)

RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers
por: De, Pradip, et al.
Publicado: (2016)

High Expression of FGD3, a Putative Regulator of Cell Morphology and Motility, Is Prognostic of Favorable Outcome in Multiple Cancers
por: Willis, Scooter, et al.
Publicado: (2017)

The miR‐200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR‐3 and MES‐OV cells
por: Brozovic, Anamaria, et al.
Publicado: (2015)

Decreased levels of baseline and drug-induced tubulin polymerisation are hallmarks of resistance to taxanes in ovarian cancer cells and are associated with epithelial-to-mesenchymal transition
por: Duran, George E, et al.
Publicado: (2017)

Enriched transcription factor signatures in triple negative breast cancer indicates possible targeted therapies with existing drugs
por: Willis, Scooter, et al.
Publicado: (2015)

Differential Activation of Wnt-β-Catenin Pathway in Triple Negative Breast Cancer Increases MMP7 in a PTEN Dependent Manner
por: Dey, Nandini, et al.
Publicado: (2013)

Independent Validation of EarlyR Gene Signature in BIG 1-98: A Randomized, Double-Blind, Phase III Trial Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor–Positive, Early Breast Cancer
por: Buechler, Steven A, et al.
Publicado: (2019)

The Syk inhibitor R406 is a modulator of P-glycoprotein (ABCB1)-mediated multidrug resistance
por: Duran, George E., et al.
Publicado: (2019)

Mutual information identifies sequence positions conserved within the nuclear receptor superfamily: approach reveals functionally important regions for DNA binding specificity
por: Willis, Scooter, et al.
Publicado: (2011)

Prostate cancer genes associated with TMPRSS2–ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts
por: Barwick, B G, et al.
Publicado: (2010)

A phase I study of an agonist anti-CD27 human antibody (CDX-1127) in patients with advanced hematologic malignancies or solid tumors
por: Ansell, Stephen, et al.
Publicado: (2013)

Molecular characterisation of formalin-fixed paraffin-embedded (FFPE) breast tumour specimens using a custom 512-gene breast cancer bead array-based platform
por: Abramovitz, M, et al.
Publicado: (2011)

Triple Fluorescence staining to Evaluate Mechanism-based Apoptosis following Chemotherapeutic and Targeted Anti-cancer Drugs in Live Tumor Cells
por: De, Pradip, et al.
Publicado: (2018)

The Prognostic Value of Cardiac Biomarkers and Echocardiography in Critical COVID-19
por: Zwaenepoel, Bert, et al.
Publicado: (2021)

Update on the utility of prognostic biomarkers in ovarian cancer
por: Markman, Maurie
Publicado: (2009)

Promises and caveats of in silico biomarker discovery
por: Pusztai, L, et al.
Publicado: (2008)

Cytokines as Prognostic Biomarkers of Epithelial Ovarian Cancer (EOC): A Systematic Review and Meta-Analysis
por: Fahmi, Moh Nailul, et al.
Publicado: (2021)

Desmoglein-2 as a prognostic and biomarker in ovarian cancer
por: Kim, Jiho, et al.
Publicado: (2020)

Screening and prognostic value of potential biomarkers for ovarian cancer
por: Li, Huiqin, et al.
Publicado: (2021)

Research Progress in Prognostic Factors and Biomarkers of Ovarian Cancer
por: Liu, Shuna, et al.
Publicado: (2021)

SPON1 is an independent prognostic biomarker for ovarian cancer
por: Miyakawa, Ryoya, et al.
Publicado: (2023)

Utilizing Tumor and Plasma Liquid Biopsy in Treatment Decision Making for an Estrogen Receptor-Positive Advanced Breast Cancer Patient
por: Xu, Bing, et al.
Publicado: (2017)

Neutrophil-to-Lymphocyte Ratio Is a Potential Prognostic Biomarker in Patients with Ovarian Cancer: A Meta-Analysis
por: Chen, Shubo, et al.
Publicado: (2017)

Inexpensive Systemic Inflammatory Biomarkers in Ovarian Cancer: An Umbrella Systematic Review of 17 Prognostic Meta-Analyses
por: El Bairi, Khalid, et al.
Publicado: (2021)

Elevated APOBEC3B Correlates with Poor Outcomes for Estrogen-Receptor-Positive Breast Cancers
por: Sieuwerts, Anieta M., et al.
Publicado: (2014)

A metastatic colon adenocarcinoma harboring BRAF V600E has a durable major response to dabrafenib/trametinib and chemotherapy
por: Williams, Casey B, et al.
Publicado: (2015)

Plasma miRNAs as Diagnostic and Prognostic Biomarkers for Ovarian Cancer
por: Zheng, Hong, et al.
Publicado: (2013)

Identification of potential biomarkers in ovarian carcinoma and an evaluation of their prognostic value
por: Cai, Junyan, et al.
Publicado: (2021)

RB1 Is an Immune-Related Prognostic Biomarker for Ovarian Cancer
por: Xie, Biao, et al.
Publicado: (2022)

Tissue Biomarkers in Prognostication of Serous Ovarian Cancer following Neoadjuvant Chemotherapy
por: Khandakar, Binny, et al.
Publicado: (2014)

Pretreatment lymphocytopenia is an adverse prognostic biomarker in advanced‐stage ovarian cancer
por: Lee, Yong Jae, et al.
Publicado: (2019)

OSov: An Interactive Web Server to Evaluate Prognostic Biomarkers for Ovarian Cancer
por: Yan, Zhongyi, et al.
Publicado: (2021)

Ferroptosis-Related Long Noncoding RNAs as Prognostic Biomarkers for Ovarian Cancer
por: Wang, Kaili, et al.
Publicado: (2022)

Identifying ITGB2 as a Potential Prognostic Biomarker in Ovarian Cancer
por: Li, Chanyuan, et al.
Publicado: (2023)

Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer
por: Győrffy, Balázs
Publicado: (2023)

Bayesian meta-analysis now – let's do it
por: K. Hackenberger, Branimir
Publicado: (2020)

A method for detecting and correcting feature misidentification on expression microarrays
por: Tu, I-Ping, et al.
Publicado: (2004)

Single-Strain Probiotic Lactobacilli for the Treatment of Atopic Dermatitis in Children: A Systematic Review and Meta-Analysis
por: Fijan, Sabina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6frbu0n8ngsu37h9l3a9sa3g16